Abstract

Acute kidney injury (AKI) is a systemic disease that affects energy metabolism in various remote organs in murine models of ischemic AKI. However, AKI-mediated effects in the liver have not been comprehensively assessed. After inducing ischemic AKI in 8–10-week-old, male C57BL/6 mice, mass spectrometry metabolomics revealed that the liver had the most distinct phenotype 24 h after AKI versus 4 h and 7 days. Follow up studies with in vivo [13C6]-glucose tracing on liver and kidney 24 h after AKI revealed 4 major findings: (1) increased flux through glycolysis and the tricarboxylic (TCA) cycle in both kidney and liver; (2) depleted hepatic glutathione levels and its intermediates despite unchanged level of reactive oxygen species, suggesting glutathione consumption exceeds production due to systemic oxidative stress after AKI; (3) hepatic ATP depletion despite unchanged rate of mitochondrial respiration, suggesting increased ATP consumption relative to production; (4) increased hepatic and renal urea cycle intermediates suggesting hypercatabolism and upregulation of the urea cycle independent of impaired renal clearance of nitrogenous waste. Taken together, this is the first study to describe the hepatic metabolome after ischemic AKI in a murine model and demonstrates that there is significant liver-kidney crosstalk after AKI.

Details

Title
Disruption in glutathione metabolism and altered energy production in the liver and kidney after ischemic acute kidney injury in mice
Author
Baker, Peter R. 1 ; Li, Amy S. 2 ; Griffin, Benjamin R. 3 ; Gil, Hyo-Wook 4 ; Orlicky, David J. 5 ; Fox, Benjamin M. 2 ; Park, Bryan 6 ; Sparagna, Genevieve C. 7 ; Goff, Jared 7 ; Altmann, Christopher 2 ; Elajaili, Hanan 8 ; Okamura, Kayo 2 ; He, Zhibin 2 ; Stephenson, Daniel 9 ; D’Alessandro, Angelo 9 ; Reisz, Julie A. 9 ; Nozik, Eva S. 8 ; Sucharov, Carmen C. 7 ; Faubel, Sarah 2 

 University of Colorado Anschutz Medical Campus, Division of Clinical Genetics and Metabolism, Department of Pediatrics, Aurora, USA (GRID:grid.430503.1) (ISNI:0000 0001 0703 675X) 
 University of Colorado Anschutz Medical Campus, Division of Renal Diseases and Hypertension, Department of Internal Medicine, Aurora, USA (GRID:grid.430503.1) (ISNI:0000 0001 0703 675X) 
 University of Iowa Carver College of Medicine, Division of Nephrology, Department of Medicine, Iowa City, USA (GRID:grid.214572.7) (ISNI:0000 0004 1936 8294) 
 University of Colorado Anschutz Medical Campus, Division of Renal Diseases and Hypertension, Department of Internal Medicine, Aurora, USA (GRID:grid.430503.1) (ISNI:0000 0001 0703 675X); Soonchunhyang University Cheonan Hospital, Department of Internal Medicine, Cheonan, Republic of Korea (GRID:grid.412677.1) (ISNI:0000 0004 1798 4157) 
 University of Colorado Anschutz Medical Campus, Department of Pathology, Aurora, USA (GRID:grid.430503.1) (ISNI:0000 0001 0703 675X) 
 University of Colorado Anschutz Medical Campus, Division of Pulmonary Sciences and Critical Care, Department of Internal Medicine, Aurora, USA (GRID:grid.430503.1) (ISNI:0000 0001 0703 675X) 
 University of Colorado Anschutz Medical Campus, Division of Cardiology, Department of Internal Medicine, Aurora, USA (GRID:grid.430503.1) (ISNI:0000 0001 0703 675X) 
 University of Colorado Anschutz Medical Campus, Division of Pediatric Critical Care, Department of Pediatrics, Aurora, USA (GRID:grid.430503.1) (ISNI:0000 0001 0703 675X) 
 University of Colorado Anschutz Medical Campus, Department of Biochemistry and Molecular Genetics, Aurora, USA (GRID:grid.430503.1) (ISNI:0000 0001 0703 675X) 
Pages
13862
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3068494748
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.